ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Scopus Q2SCImago #9,415Gold OA

Contemporary Clinical Trials Communications

Identifier (ISSN):2451-8654(Print)
•
Publisher:Elsevier
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
1.5↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Contemporary Clinical Trials Communications

WoS Q4
01121.520231.420241.420251.52026
Annual Impact Factor Metric
Current (2026):1.5
Scopus SJR & RankScopus Q2
0.625
#9,415

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
34

34 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
169articles/year
100% Gold OA•96.84% Original Research

Aims & Scope

Contemporary Clinical Trials Communications is an international peer reviewed open access journal that publishes articles pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from a wide range of disciplines including medicine, life science, pharmaceutical science, biostatistics, epidemiology, computer science, management science, behavioral science, and bioethics. Contemporary Clinical Trials Communications is unique in that it is outside the confines of disease specifications, and it strives to increase the transparency of medical research and reduce publication bias by publishing scientifically valid original research findings irrespective of their perceived importance, significance or impact. Both randomized and non-randomized trials are within the scope of the Journal. Some common topics include trial design rationale and methods, operational methodologies and challenges, and positive and negative trial results. In addition to original research, the Journal also welcomes other types of communications including, but are not limited to, methodology reviews, perspectives and discussions. Through timely dissemination of advances in clinical trials, the goal of Contemporary Clinical Trials Communications is to serve as a platform to enhance the communication and collaboration within the global clinical trials community that ultimately advances this field of research for the benefit of patients.

Topics Covered (Recognized by AI)
Medicine96%Internal medicine85.6%Pathology84.4%Biology78.6%Surgery62.5%Psychology61%Randomized controlled trial52.8%Psychiatry49.4%Bioinformatics42.8%Clinical trial40.7%Nursing38.7%Political science33.3%Law32.8%Alternative medicine32.8%Economics31.2%Computer science31%Mathematics30.2%Sociology30.1%Physical therapy29%Statistics27.2%Genetics22.9%Intervention (counseling)21.9%Chemistry21.6%Family medicine20.3%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q4
Rank146/191
IndexESCI
JCIESCI2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q3
Rank139/191
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.5
Articles / Year79
Total Citations8
2025
IF1.4
Articles / Year161
Total Citations209
2024
IF1.4
Articles / Year163
Total Citations488
2023
IF1.5
Articles / Year189
Total Citations949
2022
IF—
Articles / Year163
Total Citations1,168

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,415Scopus Q2SCImago Profile
Scopus Coverage:2015-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.625

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.62

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,073 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations823
3-Year Documents478
Citable Documents476

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate58.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2
PharmacologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区MEDICINE, RESEARCH & EXPERIMENTAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Contemporary Clinical Trials Communications (ISSN: 2451-8654) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Elsevier in United States. The periodical holds a Journal Impact Factor (JIF) of 1.50, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.625 (Q2), an H-index of 34.

The journal enforces rigorous peer evaluation with an annual output of approximately 169 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,073 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Elsevier
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: e2543ce3-d7c5-46c4-8439-d23ad7d2c15f
Database Updated: 2026-10-16